At a glance
This program funds early-stage, high-risk research on tuberous sclerosis complex that could lead to new ideas or future studies, and it does not allow clinical trials. Eligible applicants include U.S. Department of War organizations and foreign or domestic, for-profit or nonprofit organizations, with eligible individuals named as principal investigator; cost sharing is not required. The program expects about $2.1 million to support about six awards, with up to $350,000 in total costs per award and a maximum project period of 2 years. There are no geographic restrictions stated, and applications from Department of War investigators and multidisciplinary collaborations are encouraged.
What it funds
Official description from grants.gov
Summary: The fiscal year 2026 (FY26) Tuberous Sclerosis Complex Research Program (TSCRP) Exploration-Hypothesis Development Award (EHDA) supports the initial exploration of innovative, high-risk, high-gain and potentially groundbreaking concepts in the tuberous sclerosis complex (TSC) research field. Distinctive Features: Preliminary Data is not required. Applications should demonstrate the ability to achieve interpretable results in the absence of preliminary data supporting the hypothesis.
Who can apply
- Unrestricted